Log in to save to my catalogue

FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion

FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ce1218a123b441078ff4677e07ff1579

FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion

About this item

Full title

FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion

Publisher

England: BioMed Central Ltd

Journal title

Journal of hematology and oncology, 2024-02, Vol.17 (1), p.9-9, Article 9

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Emerging evidences suggest that aberrant metabolites contributes to the immunosuppressive microenvironment that leads to cancer immune evasion. Among tumor immunosuppressive cells, myeloid-derived suppressor cells (MDSCs) are pathologically activated and extremely immunosuppressive, which are closely associated with poor clinical outcomes of cancer...

Alternative Titles

Full title

FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ce1218a123b441078ff4677e07ff1579

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ce1218a123b441078ff4677e07ff1579

Other Identifiers

ISSN

1756-8722

E-ISSN

1756-8722

DOI

10.1186/s13045-024-01529-6

How to access this item